Sentences with phrase «by antiretroviral therapy»

«Throughout our decade - long study with more than 1,600 heterosexual couples, we did not observe HIV transmission when the HIV - infected partner's virus was stably suppressed by antiretroviral therapy,» said Myron Cohen, M.D., the study's principal investigator.

Not exact matches

By the mid-1990s, the terror of the early AIDS epidemic had subsided in many western countries, as antiretroviral therapy transformed the once - deadly disease into a chronic condition.

As with the general population, the organization recommends that all HIV - positive pregnant women begin antiretroviral therapy in their first trimester if their CD4 counts drop to 350 (instead of the previous threshold of 200), and by the second trimester regardless of CD4 count.

The HIV prevention strategy whose impact was observed in the study is based on earlier findings by the National Institutes of Health (NIH) and others demonstrating the protective effect of voluntary medical male circumcision for HIV - uninfected men and of HIV - suppressing antiretroviral therapy (ART) for halting sexual transmission of the virus to uninfected partners.

Investigators report today that starting antiretroviral therapy early reduced HIV transmission by 93 percent over the course of the study.

«From a treatment provider perspective, this is very exciting as we have been waiting for a simple, affordable, robust treatment tolerated by all patients groups, including those whose treatment outcomes are currently poorer, like patients under antiretroviral therapy,» said Pierre Mendiharat, Deputy Operations Director for Médecins Sans Frontières / Doctors Without Borders (MSF).

Highly active antiretroviral therapy (HAART) has transformed the outlook for patients infected with HIV by suppressing the replication of the virus in the body.

A new study suggests Ontario is nearing ambitious United Nations targets for ending the AIDS epidemics: By 2020, 90 per cent of all people living with HIV should know their HIV status, 90 per cent of all people diagnosed with HIV are receiving sustained antiretroviral drug therapy and 90 per cent of people on ART have a very low or undetectable levels of the virus.

That is, by 2020, 90 percent of people living with HIV should know their HIV status, 90 percent of those who test positive for HIV should begin antiretroviral therapy (ART), and of those who begin ART, 90 percent should achieve virologic suppression, meaning their virus levels are not detectable using standard tests.

Early use of antiretroviral therapy for HIV, Cohen found, slashed the risk of transmitting the virus by 96 percent.

A new study by The HIV Prevention Trials Network (HPTN) shows that financial incentives did not have an overall effect on motivating HIV - positive patients to take their HIV antiretroviral therapy (ART) medication regularly and maintain control of their HIV.

By enabling people unaware of their HIV infection to get tested, get engaged in care, and take antiretroviral therapy, HIV - positive people have a better chance of living longer, healthier lives and greatly reducing their chance of passing the virus on to their sex partners.

In HIV - infected patients undergoing antiretroviral therapy (ART), ongoing HIV replication in lymphoid tissues such as the lymph nodes helps maintain stores, or reservoirs, of the virus, a new study funded by the National Institutes of Health suggests.

«This one - two punch of discoveries underscores the critical value of basic science — by uncovering the major cause of CD4 T cell depletion in AIDS, Dr. Greene's lab has been able to identify a potential new therapy for blocking the disease's progression and improving on current antiretroviral medications.»

The drug, however, is so far meant for use only by patients infected with a particular strain of the virus — CCR5 - tropic HIV - 1 — that is resistant to many other antiretroviral therapies.

By 2010, the International HIV Controllers Study had identified and enrolled in various studies 1,400 participants who consistently maintained viral loads below 2,000 copies / ml in the absence of antiretroviral therapy.

PHILADELPHIA --(April 18, 2018)-- An international team focused on HIV cure research spearheaded by The Wistar Institute in collaboration with the University of Pennsylvania and Vall d'Hebron Research Institute (VHIR) in Barcelona, Spain, established that the CD32 molecule is not a preferential biomarker to identify HIV silent reservoirs within the immune system of patients undergoing antiretroviral therapy (ART), as proposed by a recent landmark study.

«By revealing how and why latency is established and maintained, we may be able to develop new avenues to treat it — something current antiretroviral therapies do not address.»

If you are HIV - positive, you can protect your partner and yourself by taking antiretroviral therapy — medicines that reduce the amount of HIV in your blood and body.

Studies have also shown that clinicians — as well as pharmacists — and users are concerned about the impact of increased access to EC on sexual risk - taking behaviors and sexually transmitted infections (STIs).8 - 10 Recent research in the field of STI and human immunodeficiency virus (HIV) prevention has shown that sexual risk - taking behaviors and unprotected intercourse in men have increased after the introduction of highly active antiretroviral therapy.11, 12 No study has yet tested whether increased access to EC might increase STI risk by affecting sexual behavior, including frequency of intercourse and number of partners.

As this article about prevention as treatment (PasT) outlines, a combination of potent antiretroviral therapy (ART) has «changed the course of the HIV epidemic», not only significantly improving life expectancy (to decades rather than months) but also dramatically reducing the risk, by almost 100 per cent in one landmark trial, of transmitting the infection to sexual and drug - using partners.